Ann: Andromeda and Minotaur to Combine, page-12

as far as I can see it will apply for the whole offer period which means both ADN and MEP will trade as per normal but share price should reflect the ratio of the deal

there could be significant volatility

effectively MEP share price should reflect 1.15 times ADN share price .. If it does not there is arbitrage at play

furthermore, MEP holders have pro rata exposure to the spin off but I don't know what the record date is for that

So yeh I think there will be horse trading of shares in a big way this can be positive and negative but that's markets .. what it does though is remove some of the uncertainty surrounding the relationship and ADN control which is now total

pity about the DFS being delayed but I suspect there will be big news in the interim